Premier Biomedical, Inc.
BIEIOTCHealthcare● Active
$0.00
$-0.00(-7.69%)
Market Cap$1199977
P/E Ratio—
52W High$0.002
52W Low$0.0003
Premier Biomedical, Inc. (BIEI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BIEI · earnings · updated Jun 15, 2026
Latest Earnings
Q3 FY2019Report Date: Sep 30, 2019EPS Actual
-$0.01
Revenue
$0.00B
Fiscal Period
Q3 FY2019
FY ends December
Report Date
Sep 30, 2019
After Market Close
BIEI reports quarterly as a OTC-listed Medical - Pharmaceuticals company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
79
days
Expected Date
Sep 2, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.01
Rev. $1.41B
Days Away79
Expected DateSep 2, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.01
Rev. Est.$1.41B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2020 | Nov 2, 2020 | — | — | — | — | — | — |
| — Q3 FY2019 | Sep 30, 2019 | — | -$0.01 | — | $0.00B | — | — |
| — Q2 FY2019 | Jun 30, 2019 | — | -$0.02 | — | $0.00B | — | — |
| — Q1 FY2019 | Mar 31, 2019 | — | $0.01 | — | $0.00B | — | — |
| — Q4 FY2018 | Dec 31, 2018 | — | -$0.03 | — | $0.00B | — | — |
| — Q3 FY2018 | Sep 30, 2018 | — | -$0.11 | — | $0.00B | — | — |
| — Q2 FY2018 | Jun 30, 2018 | — | -$0.03 | — | $0.00B | — | — |
| — Q1 FY2018 | Mar 31, 2018 | — | $0.20 | — | $0.00B | — | — |
Q4 FY2020
Nov 2, 2020
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2019
Sep 30, 2019
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2019
Jun 30, 2019
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2019
Mar 31, 2019
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2018
Dec 31, 2018
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2018
Sep 30, 2018
EPS Actual
-$0.11
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2018
Jun 30, 2018
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2018
Mar 31, 2018
EPS Actual
$0.20
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
No analyst estimates available for BIEI.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2019 | Sep 30, 2019 | — | $0.01 | $0.01 | -4.35% |
| — Q2 FY2019 | Jun 30, 2019 | — | $0.02 | $0.02 | -6.25% |
| — Q1 FY2019 | Mar 31, 2019 | — | $0.04 | $0.04 | +4.75% |
| — Q4 FY2018 | Dec 31, 2018 | — | $0.09 | $0.08 | -6.00% |
| — Q3 FY2018 | Sep 30, 2018 | — | $0.19 | $0.12 | -34.74% |
| — Q2 FY2018 | Jun 30, 2018 | — | $0.38 | $0.35 | -8.13% |
| — Q1 FY2018 | Mar 31, 2018 | — | $0.00 | $0.00 | -3.03% |
| — Q4 FY2017 | Dec 31, 2017 | — | $0.00 | $0.00 | +14.29% |
Q3 FY2019-4.35%
Report Date
Sep 30, 2019
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q2 FY2019-6.25%
Report Date
Jun 30, 2019
EPS Beat/Miss
—
Price Before
$0.02
Price After
$0.02
Q1 FY2019+4.75%
Report Date
Mar 31, 2019
EPS Beat/Miss
—
Price Before
$0.04
Price After
$0.04
Q4 FY2018-6.00%
Report Date
Dec 31, 2018
EPS Beat/Miss
—
Price Before
$0.09
Price After
$0.08
Q3 FY2018-34.74%
Report Date
Sep 30, 2018
EPS Beat/Miss
—
Price Before
$0.19
Price After
$0.12
Q2 FY2018-8.13%
Report Date
Jun 30, 2018
EPS Beat/Miss
—
Price Before
$0.38
Price After
$0.35
Q1 FY2018-3.03%
Report Date
Mar 31, 2018
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Q4 FY2017+14.29%
Report Date
Dec 31, 2017
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.00
Beat Rate0 / 8 quarters
Largest Move-34.74% (Q3 FY2018)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BIEI ends December
Premier Biomedical, Inc. (BIEI) most recently reported earnings on September 30, 2019 for Q3 FY2019, posting EPS of $-0.01 (in line with the analyst consensus of —). The next BIEI earnings date is expected around September 2, 2026.
Each quarter, investors track BIEI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BIEI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BIEI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BIEI earnings · 4 questionsPremier Biomedical, Inc.'s next earnings report is expected around September 2, 2026. BIEI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BIEI historically reports after market close (AMC).
BIEI earnings datewhen is BIEI earningsBIEI next earnings datewhen does BIEI report earningsBIEI earnings calendar
▸ Source: FMP · Premier Biomedical, Inc. SEC filings · US GAAP · Premier Biomedical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026